Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection
doi: 10.3389/fcimb.2021.689707
Figure Lengend Snippet: TRIM22 is differentially expressed in a cell-type dependent manner. (A–C) Primary and hTERT immortalized human lung fibroblast (MRC5 and MRC5t, respectively), lung adenocarcinoma epithelial (A549), and SV40-transformed human kidney epithelial (HEK 293T; 293T) cells were treated with (+) or without (-) IFN-β (100 IU/ml) for 24 h. (A) Western blots of WCLs probed for TRIM22 expression. Actin is shown as a loading control. (B, C) qRT-PCR quantitation of TRIM22 and Mx1 mRNA transcript expression levels, respectively. Values normalized to MRC5t cells without IFN treatment (dotted line); n=3, means and SD shown. (D) Confocal microscopy images of MRC5t and A549 cells with or without IFN treatment (as in A ). TRIM22 was labelled by indirect immunofluorescence. Nuclei were stained with DAPI. (E) MRC5t and A549 cells were mock-treated, IFN- β (100 IU/ml) stimulated or infected with IAV (A/WSN/1933(H1N1), WSN) at a MOI of 1 PFU/cell (based on MDCK titres) for the indicated times (hours; h). WCLs were analyzed by western blots for TRIM22, Mx1, and viral protein (NP and NS1) expression. Actin is shown as a loading control. (F) A549 cells were infected with IAV (WSN; MOI of 0.01 PFU/cell based on MDCK titres) and harvested at the indicated times prior to western blotting (as in E ).
Article Snippet: Primary human foetal lung fibroblast (MRC5) cells were purchased from the European Collection of Authenticated Cell Cultures (ECACC; 05072101).
Techniques: Transformation Assay, Western Blot, Expressing, Control, Quantitative RT-PCR, Quantitation Assay, Confocal Microscopy, Immunofluorescence, Staining, Infection